Education
About Us
Working with TipRanks
Follow Us
John Martin Arnold Insider Profile
4 Followers
John Martin Arnold, Director at Volatus Aerospace, holds 110.00K shares in Volatus Aerospace (Ticker: TAKOF), holds 125.00K shares in NurExone Biologic (Ticker: TSE:NRX). Most recently, John Martin Arnold Bought ― shares of Volatus Aerospace on Sep 26, 2013 for an estimated value of $20.00K.
John Martin Arnold has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Martin Arnold holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by John Martin Arnold
John Martin Arnold's Trading History
Volatus Aerospace
Sep 26, 2013
Director
Informative Buy
20.00K
$62.48K
NurExone Biologic
―
Executive
―
C$75.00K
List of latest transactions for each holding click on a transaction to see John Martin Arnold's performance on stock
You May Also Like
John Martin Arnold insider profile FAQ
What is the percentage of profitable transactions made by John Martin Arnold?
The percentage of profitable transactions made by John Martin Arnold is ―.
What is the average return per transaction made by John Martin Arnold?
The average return per transaction made by John Martin Arnold is ―.
What stocks does John Martin Arnold hold?
John Martin Arnold holds: TAKOF, TSE:NRX stocks.
What was John Martin Arnold’s latest transaction?
John Martin Arnold latest transaction was an Informative Buy of $20.00K.
What was John Martin Arnold's most profitable transaction?
John Martin Arnold’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is John Martin Arnold's role in Volatus Aerospace?
John Martin Arnold's role in Volatus Aerospace is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.